IP Verse

Combination Therapy With A Hyaluronan-Degrading Enzyme And An Immune Checkpoint Inhibitor

Patent No. EP3186281 (titled "Combination Therapy With A Hyaluronan-Degrading Enzyme And An Immune Checkpoint Inhibitor") was filed by Halozyme on Aug 28, 2015. The application was issued on Apr 10, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
J A KEMPJan 10, 2020J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3186281

HALOZYME
Application Number
EP15760604A
Filing Date
Aug 28, 2015
Status
Revoked
Jul 17, 2020
Publication Date
Apr 10, 2019
External Links
Slate, Register , Google Patents